BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moalem K, Baber U, Chandrasekhar J, Claessen BE, Sartori S, Aquino M, Dangas G, Iakovou I, Colombo A, Kini A, Gibson M, Krucoff M, Chieffo A, Moliterno D, Witzenbichler B, Pocock S, Mehran R. Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry. Clin Res Cardiol 2019;108:643-50. [DOI: 10.1007/s00392-018-1392-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Chourase M, Sharma N, Saunik S, Duggal M, Danaei G, Duggal B. The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence. BMC Cardiovasc Disord 2022;22:238. [PMID: 35606724 DOI: 10.1186/s12872-022-02677-8] [Reference Citation Analysis]
2 Malik J, Yousaf H, Abbasi W, Hameed N, Mohsin M, Shahid AW, Fatima M. Incidence, predictors, and outcomes of DAPT non-compliance in planned vs. ad hoc PCI in chronic coronary syndrome. PLoS One 2021;16:e0254941. [PMID: 34270595 DOI: 10.1371/journal.pone.0254941] [Reference Citation Analysis]
3 Kuramitsu S, Sonoda S, Ando K, Otake H, Natsuaki M, Anai R, Honda Y, Kadota K, Kobayashi Y, Kimura T. Drug-eluting stent thrombosis: current and future perspectives. Cardiovasc Interv Ther 2021;36:158-68. [PMID: 33439454 DOI: 10.1007/s12928-021-00754-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Tersalvi G, Biasco L, Cioffi GM, Pedrazzini G. Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective. J Clin Med 2020;9:E2064. [PMID: 32630233 DOI: 10.3390/jcm9072064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Hou Y, Yue Y, Zhao M, Jiang S. Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction. Medicine (Baltimore) 2019;98:e17826. [PMID: 31689870 DOI: 10.1097/MD.0000000000017826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 De Luca L, Colivicchi F, Meessen J, Uguccioni M, Piscione F, Bernabò P, Lardieri G, Granatelli A, Gabrielli D, Gulizia MM; EYESHOT Post-MI Investigators. How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study. Clin Cardiol 2019;42:1113-20. [PMID: 31471975 DOI: 10.1002/clc.23262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Samardzic J, Bozina N, Skoric B, Ganoci L, Krpan M, Petricevic M, Pasalic M, Bozina T, Pavasovic S, Cikes M, Milicic D. Impact of Continuous P2Y12 Inhibition Tailoring in Acute Coronary Syndrome and Genetically Impaired Clopidogrel Absorption. J Cardiovasc Pharmacol 2020;75:174-9. [PMID: 32023226 DOI: 10.1097/FJC.0000000000000767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Björklund E, Malm CJ, Nielsen SJ, Hansson EC, Tygesen H, Romlin BS, Martinsson A, Omerovic E, Pivodic A, Jeppsson A. Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome. JAMA Netw Open 2021;4:e2122597. [PMID: 34436610 DOI: 10.1001/jamanetworkopen.2021.22597] [Reference Citation Analysis]
9 Georges JL, Cherif G, Ajlani B. [Optimal duration of dual antiplatelet therapy after coronary stent placement or acute coronary syndrome. Is customisation possible?]. Ann Cardiol Angeiol (Paris) 2019;68:347-57. [PMID: 31471043 DOI: 10.1016/j.ancard.2019.07.011] [Reference Citation Analysis]
10 Krackhardt F, Kočka V, Waliszewski M, Toušek P, Janek B, Trenčan M, Krajči P, Lozano F, Roman KG, Otaegui I, Del Blanco BG, Del Olmo VV, Nofrerías EF, Wachowiak L, Heang TM, Ahn TH, Jeong MH, Jung BC, Han KR, Piot C, Sebagh L, Rischner J, Pansieri M, Leschke M. Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice. Medicine (Baltimore) 2020;99:e19119. [PMID: 32080086 DOI: 10.1097/MD.0000000000019119] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kedhi E, Verdoia M, Suryapranata H, Damen S, Camaro C, Benit E, Barbieri L, Rasoul S, Liew HB, Polad J, Ahmad WA, Zambahari R, Lalmand J, van der Schaaf RJ, Koh TH, Timmermans P Sr, Dilling-Boer D, Veenstra LF, Van' T Hof AW, Lee SW, Roolvink V, Ligtenberg E, Postma S, Kolkman EJ, Brouwer MA, Dudek D, De Luca G. Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial. Atherosclerosis 2021;321:39-44. [PMID: 33639478 DOI: 10.1016/j.atherosclerosis.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]